Novartis in Basel-Stadt

Aeon

B

Apr 18

Tiny, entangled universes that form or fizzle out – a theory of the quantum multiverse | Aeon Videos

aeon.co/videos/tiny-entangled-universes-that-form-or-fizzle-out-a-theory-of-the-quantum-multiverse

1 similar article

288

1

Investor's Business Daily

D

Apr 23

How Novartis Rode Two Blockbusters To A Three-Day Sprint: Novartis stock jumped Tuesday after the drugmaker topped first-quarter sales and earnings forecasts ...

investors.com/news/technology/novartis-stock-novartis-earnings-q1-2024/

Quick Glance: Positive Quarterly Results Lead to Guidance Increase at Novartis

Novartis raises its annual guidance following a successful first quarter.

Revenue increased by 10% to $11.83 billion, with adjusted operating income growing by 16% to $4.54 billion.

CEO Vas Narasimhan is focusing more on drug development and has been active in mergers and acquisitions.

Novartis has secured promising drugs, including an experimental prostate cancer drug from Arvinas and the company MorphoSys, which develops cancer treatments, for 2.7 billion euros.

38

Apr 23

Novartis accused of promoting asthma drug for preterm labor despite brain risk

30

Mar 28

Former England captain and Man City defender Houghton to retire Show more

22

Apr 16

Job cuts at Novartis and Roche: a blow for the research center: The Swiss pharmaceutical industry is facing a bloodletting. Due to reorganizations at Novartis ...

nzz.ch/wirtschaft/novartis-und-roche-kuendigen-hochqualifizierten-spezialisten-ld.1825752

8

Feb 11

AHV vote: Now the top earners come to the checkout: Sergio Ermotti and Novartis boss Vas Narasimhan pay over a million francs annually into the AHV ...

tagesanzeiger.ch/ahv-abstimmung-jetzt-kommen-die-spitzenverdiener-an-die-kasse-692829873364

113

Apr 11

Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials

qz.com/norvartis-morphosys-deal-cancer-trials-pause-1851403095

1

Apr 09

Novartis to cut 680 jobs in product development: Novartis is to cut up to 680 jobs in its development organisation, which helps bring its drugs to market ...

reuters.com/business/world-at-work/novartis-cut-680-jobs-product-development-2024-04-09/

18

Apr 12

Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...

reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/

11

Apr 23

BREAKING: FTSE 100 hits fresh record high at the open as European markets rise European markets live updates: stocks, news, PMI data and earnings

31

Mar 07

CEO pay: can Switzerland compete with the US?: Swiss CEOs are some of the best paid in Europe but compared to peers in the US, their salaries look modest.

swissinfo.ch/eng/multinational-companies/ceo-pay-can-switzerland-compete-with-the-us/73415382

0 similar articles

55

25

Frankfurter Rundschau

C+

Apr 10

Pharmaceutical company announces job cuts - hundreds of employees in two countries affected

fr.de/wirtschaft/pharmakonzern-kuendigt-stellenabbau-an-hunderte-mitarbeiter-in-zwei-laendern-betroffen-zr-92997399.html

27

Feb 08

For decades, there were questionable drug trials at the Münsterlingen psychiatric clinic. Now Novartis is contributing to the financial compensation. 👉 brnw.ch/21wGMOa

36

Mar 18

US appeals court revives Regeneron's antitrust lawsuit against Novartis: A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals ...

reuters.com/legal/us-appeals-court-revives-regenerons-antitrust-lawsuit-against-novartis-2024-03-18/

19

Jan 31

Pharmaceutical industry: Novartis has doubled CEO Narasimhan's compensation: The American received the equivalent of more than 17 million euros in 2023 ...

handelsblatt.com/unternehmen/industrie/pharmabranche-novartis-hat-verguetung-von-konzernchef-narasimhan-verdoppelt/100011818.html

87

Feb 06

Novartis acquires German biotech MorphoSys for CHF2.5 billion: Even after its numerous acquisitions in 2023, the pharmaceutical company Novartis has not yet ...

swissinfo.ch/eng/business/novartis-acquires-german-biotech-morphosys-for-chf2_5-billion/49189882

17

Apr 23

Whatever happened to the world’s most expensive drug?: Zolgensma came to the market five years ago with a price tag of $2.1 million. What happened to it?

swissinfo.ch/eng/multinational-companies/whatever-happened-to-the-worlds-most-expensive-drug/75388576

6

Feb 29

Sandoz enters $265 mln settlement agreement in U.S. price-fixing case

16

Jan 11

Novartis drops pursuit of Cytokinetics - source: Swiss drugmaker Novartis (NOVN.S) has backed away from its pursuit of Cytokinetics (CYTK.O) ...

reuters.com/business/healthcare-pharmaceuticals/novartis-drops-pursuit-cytokinetics-wsj-2024-01-11/

0 similar articles

2

5 1

Investor's Business Daily

D

Jan 02

This Biotech Just Catapulted 33%, Flashing A Bullish Sign: Novartis expanded its gene therapy collaboration with Voyager on Tuesday, and VYGR stock rocketed ...

investors.com/news/technology/vygr-stock-catapults-higher-after-novartis-sweetens-its-gene-therapy-deal/

3

Feb 01

School desks instead of cars: Will this parking garage one day become a primary school?

bazonline.ch/schulbaenke-statt-autos-wird-dieses-parkhaus-einst-eine-primarschule-785482089106

7

Jan 31

Novartis misses Q4 net income expectations, extends forecast: Swiss drugmaker Novartis (NOVN.S) reported a 6% gain in fourth-quarter adjusted net income on ...

reuters.com/business/healthcare-pharmaceuticals/novartis-eyes-5-annual-sales-growth-through-2028-2024-01-31/

Quick Glance: South Africa's Goalkeeper Leads Team to Africa Cup of Nations Semi-Finals

South Africa's Ronwen Williams saves four penalties, securing a spot in the Africa Cup of Nations semi-finals.

Mothobi Mvala scores decisive penalty in 2-1 shootout win after 0-0 draw, sending South Africa to their first semi-final since 2000.

Williams makes brilliant saves, carrying South Africa to victory after dominating the early exchanges and surviving several scares.

South Africa to face Nigeria in semi-final match on Wednesday.

13

Jan 23

US FDA requires 'boxed warning' for CAR-T cancer therapies

1

Feb 27

Man to spend life in prison for killing TikTok personality and his date at California movie theater

nbcnews.com/news/us-news/man-spend-life-prison-killing-tiktok-personality-date-california-movie-rcna140598

3 similar articles

5

95

Investor's Business Daily

D

Apr 11

Biotech Stocks Heat Up, Driven By A Spate Of Billion-Dollar Deals: Biotech stocks heated Thursday as Novartis scooped up a licensing pact with Arvinas and Janux ...

investors.com/news/technology/biotech-stocks-arvinas-novartis-licensing-deal-janux-takeover-interest/

7

Feb 13

Trend towards frosted facades: Architecture degenerates into a disco ball: The MSG Sphere in Las Vegas and the Novartis Pavilion in Basel reduce the façade to an ...

nzz.ch/feuilleton/trend-zu-mattscheiben-fassaden-architektur-verkommt-zur-discokugel-ld.1777408

21

Mar 06

The Novartis general meeting knew one big topic: the salary of CEO Vas Narasimhan. 👉 To the story: brnw.ch/21wHBQo

8

4

SWI swissinfo.ch

B

Feb 09

Pharmaceutical giant Novartis invested billions in Slovenia, helping turn it into a global player in generic drug production ... Show more

0:49

13

Jan 11

Novartis drops pursuit of Cytokinetics - source Show more

25

Feb 03

Münsterlingen case: Novartis pays 4 million to victims: At the Münsterlingen Psychiatric Clinic, Basel pharmaceutical companies tested substances on unwitting ...

nzz.ch/schweiz/novartis-beteiligt-sich-an-millionenentschaedigung-fuer-opfer-von-medikamententests-ld.1777071

3

Jan 08

Novartis in advanced talks to buy Cytokinetics- source: Swiss drugmaker Novartis (NOVN.S) is in the lead to acquire Cytokinetics (CYTK.O) for a deal that could ...

reuters.com/markets/deals/novartis-advanced-talks-buy-cytokinetics-wsj-2024-01-08/

Quick Glance: VW utilizing ChatGPT for driver conversations by mid-year

Volkswagen integrating ChatGPT to enable driver conversations by mid-year.

First vehicles with ChatGPT available in North America and Europe from early second quarter.

AI system capable of recognizing and responding to various demands, such as temperature adjustments and displaying nearby restaurants.

16

Jan 09

Novartis makes progress with myeloid leukaemia drug: Swiss pharma Novartis sees clinical trial superiority of Scemblix for Philadelphia chromosome-positive ...

swissinfo.ch/eng/sci-tech/novartis-makes-progress-with-myeloid-leukaemia-drug/49109142

18

Nov 30 23

FCB CEO Chris Kauffmann in an interview: "We will find the equivalent of Novartis' performance"

bazonline.ch/fcb-ceo-chris-kauffmann-im-interview-wir-finden-das-aequivalent-fuer-die-leistung-von-novartis-824286819910

20

Apr 12

Inside Vasant 'Vas' Narasimhan's transformation of Novartis, and more

forbesindia.com/article/column/inside-vasant-vas-narasimhans-transformation-of-novartis-and-more/92547/1

0 similar articles

1

Chronicle Live

C

Feb 08

Tesco thief stole 22 tubs of Lurpak worth £95 while on suspended sentence for cheese raidtinyurl.com/4naf6wzx

37

Apr 16

Q1/2024 check-up: how the Swiss economy is faring - SWI swissinfo.ch: The highlights of the Swiss economy in the first three months of 2024 - here is our ...

swissinfo.ch/eng/workplace-switzerland/q1-2024-check-up-how-the-swiss-economy-is-faring/75764295

0 similar articles

2

0

Harvard Business Review

B

Apr 22

Research: More People Use Mental Health Benefits When They Hear That Colleagues Use Them Too

hbr.org/2024/04/research-more-people-use-mental-health-benefits-when-they-hear-that-colleagues-use-them-too

33

Jan 03

Pharmaceutical companies: takeovers will reach a record level in 2023: The heavyweights among drug manufacturers took over companies for $110 billion last year ...

nzz.ch/wirtschaft/biotechnologie-ld.1772282

5

Jan 22

Sandoz to buy eye drug Cimerli in $170 million deal: Sandoz (SDZ.S) on Monday announced a deal to buy Cimerli, a biosimilar drug to treat vision impairment and ...

reuters.com/markets/deals/sandoz-buy-eye-drug-cimerli-170-million-deal-2024-01-22/

5

Mar 03

Man, 20, dies after car hits tree in Houghton-le-Spring: A man died following a crash on Thursday night and police are now appealing for witnesses

chroniclelive.co.uk/news/north-east-news/man-20-dies-after-car-28745753

31

Feb 27

Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday ... Show more

cnb.cx/3P0RYq6

10

Feb 02

Swiss drug trial victims offered millions in compensation: Some 500 victims of flawed drug tests could be eligible for compensation totaling up to CHF12 ...

swissinfo.ch/eng/sci-tech/swiss-drug-trial-victims-offered-millions-in-compensation/49179934

4

Nov 22 23

170 caravans, 220 vehicles: Travellers occupied the site at Novartis and Co.: In the municipality of Huningue near Basel, an illegal settlement with hundreds of ...

bazonline.ch/170-wohnwagen-220-fahrzeuge-fahrende-besetzten-areal-bei-novartis-und-co-703665707706

11

Nov 29 23

Novartis raises sales growth target to 5% a year through 2027: Novartis (NOVN.S) has dialled up its sales growth target to 5% per year until 2027 ...

reuters.com/business/healthcare-pharmaceuticals/novartis-aims-5-annual-sales-growth-through-2027-2023-11-28/

29

Mar 19

AstraZenca is betting $2 billion on next-generation cancer treatments: AstraZeneca is acquiring Fusion Pharmaceuticals in a $2-billion deal

qz.com/astrazeneca-fusion-pharmaceuticals-2-billion-acquisitio-1851348307

1

Dec 19 23

Swiss pharma mega-deal has healthy prognosis: A $440 billion Swiss drug deal may finally have the right formula. Back in 2001 Novartis (NOVN ...

reuters.com/breakingviews/swiss-pharma-mega-deal-has-healthy-prognosis-2023-12-19/

65

Jan 13

Novartis and Roche: Swiss pharmaceutical duo is looking for a connection: The two Swiss industry giants Roche and Novartis account for around 30 percent of the ...

diepresse.com/17989003/novartis-und-roche-schweizer-pharma-duo-sucht-anschluss

8

Apr 06

Lurpak thief jailed for going on shoplifting spree days after release from prison Lurpak thief jailed for going on Houghton-le-Spring shoplifting spree days after release from prison - Chronicle Live

11

321

Quartz

B+

Apr 14

Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up

qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812

0

Feb 02

Sports club Novartis in Stein is looking for a landlady for the clubhouse: The new person should have the freedom to decide whether this should become a “real” ...

aargauerzeitung.ch/aargau/fricktal/stein-die-mitglieder-muessen-derzeit-selbst-am-zapfhahn-stehen-der-sportclub-novartis-sucht-wirt-oder-wirtin-fuers-restaurant-ld.2573392

1

Feb 01

Roche: Competition for Ozempic & Co.: The pharmaceutical company wants to develop “the best drug against obesity,” says Roche boss Thomas Schinecker ...

bazonline.ch/roche-konkurrenz-fuer-ozempic-co-688900380622

2

Dec 20 23

A relatively quick cure to Roche’s recent struggles will be a $440 billion tie-up with Novartis, a company it has been closely linked to since Novartis bought ... Show more

1:39

17

22h

Turkey vs. Zolgensma: the battle over the world’s most expensive drug: Turkey and Novartis are in a stand-off over approval of Zolgensma - a $2 ...

swissinfo.ch/eng/multinational-companies/turkey-vs-novartis-the-battle-over-the-worlds-most-expensive-drug/76341423

0 similar articles

0

Business Standard

B

Dec 19 23

JB Chemicals buys opthalmology brands from Novartis for Rs 964 crore: JB Chemicals and Pharmaceuticals shall offer employment to the impacted associates working ...

business-standard.com/companies/news/jb-chemicals-buys-opthalmology-brands-from-novartis-for-rs-964-crore-123121901051_1.html

4

Mar 04

Tributes have been paid to a 20-year-old who lost his life days before becoming a dad. Leighton Mileson sadly died after the car he was driving left the road ... Show more

tinyurl.com/yc6hsbwu

9

Feb 05

How to recognize WHF in patients with HFrEF and improve outcomes? 🖥️ Join as experts discuss GDMT and additional therapy to tackle these clinical issues ... Show more

ms.spr.ly/6182iL0pE

0:05

2

Dec 04 23

South Africa's Aspen expands further into Asia with Sandoz China deal: Aspen Pharmacare (APNJ.J) is expanding further into China through a deal to buy the ...

reuters.com/markets/deals/south-africas-aspen-pharmacare-buy-sandozs-china-business-2023-12-04/

0 similar articles

17

4 1

IOL

C

Dec 11 23

Mandela family shocker as Houghton home lies in ruins due to family disputes: Reports indicate that the mansion, which is now a shadow of its former self ...

iol.co.za/saturday-star/news/mandela-family-shocker-as-houghton-home-lies-in-ruins-due-to-family-disputes-3be1c5ea-12ac-47fa-8dc9-e529998b87b6

26

Feb 13

Couple celebrate 40 years at the helm of The Beehive in Houghton: The landmark pub has only had three landlords since 1939.

sunderlandecho.com/business/couple-celebrate-40-years-at-the-helm-of-the-beehive-in-houghton-4516535

3

Feb 18

FDA expands use of asthma drug Xolair to treat severe food allergies: A medication used to treat asthma can now be used to help people with food allergies avoid ...

abcnews.go.com/Health/wireStory/fda-expands-asthma-drug-xolair-treat-severe-food-107297383

29

Dec 13 23

If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

cnbc.com/2023/12/13/where-ma-could-be-heading-in-the-obesity-drug-space.html

23

Nov 29 23

US FDA investigating safety risk of CAR-T cancer therapies: The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies ...

reuters.com/legal/government/us-fda-investigating-safety-risk-car-t-cancer-therapies-2023-11-28/

9

Nov 30 23

How data and partnerships can help us improve heart health at scale The Novartis Foundation has launched CARDIO4Cities and AI4HealthyCities that use data to ... Show more

www.weforum.org/agenda/2023/11/we-can-improve-heart-health-at-scale-through-data-and-partnerships?utm_source=facebook&utm_medium=social_scheduler&utm_term=Cities+and+Urbanization&utm_content=30%2F11%2F2023+00%3A00

24

Jan 16

Top pharma CEO says preparedness for a new pandemic has not improved: Vas Narasimhan, CEO of Novartis, told CNBC that he didn't believe there had been much ...

cnbc.com/2024/01/17/novartis-ceo-says-preparedness-for-a-new-pandemic-has-not-improved.html

13

Dec 04 23

Blackstone explores sale of Anthos Therapeutics -sources: Private equity firm Blackstone Inc (BX.N) is exploring the sale of Anthos Therapeutics ...

reuters.com/markets/deals/blackstone-explores-sale-anthos-therapeutics-sources-2023-12-04/

9

Dec 20 23

How data and partnerships can help us improve heart health at scale The Novartis Foundation has launched CARDIO4Cities and AI4HealthyCities that use data to ... Show more

www.weforum.org/agenda/2023/11/we-can-improve-heart-health-at-scale-through-data-and-partnerships?utm_source=facebook&utm_medium=social_scheduler&utm_term=Cities+and+Urbanization&utm_content=20%2F12%2F2023+09%3A00

0 similar articles

14

6

fcbasel1893 Nov 29 23

ℹ️ 𝗡𝗼𝘃𝗮𝗿𝘁𝗶𝘀 𝗮𝗯 𝟮𝟬𝟮𝟱 𝗻𝗶𝗰𝗵𝘁 𝗺𝗲𝗵𝗿 𝗙𝗖𝗕-𝗛 𝗮𝘂𝗽𝘁𝘀𝗽𝗼𝗻𝘀𝗼𝗿, 𝗯𝗹𝗲𝗶𝗯𝘁 𝗮𝗯𝗲𝗿 𝗮𝗻 𝗕𝗼𝗿𝗱Novartis has been the main sponsor of FC Basel 1893 since 2004 ... Show more

3

Feb 22

House Dems press drug companies on nationwide shortages: House Oversight Democrats are pressing pharmaceutical companies on the nationwide shortages of a number ...

thehill.com/homenews/house/4481653-house-oversight-democrats-pharmaceutical-companies-nationwide-drug-shortages-investigation/

3

Jan 30

Facing the Challenges: Expert Perspectives on Managing Worsening Heart Failure: How to recognize WHF in patients with HFrEF and improve outcomes? Join as experts ...

ms.spr.ly/6182iL0HK

0 similar articles

0

The Wall Street Journal

B

Jan 08

WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics: Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.

wsj.com/business/deals/novartis-in-advanced-talks-to-buy-cytokinetics-d1032569

12

Dec 19 23

On @Breakingviews : Back in 2001, Novartis took a stake in Roche and sparked speculation of a possible merger that never panned out. The companies’ divergent fortunes ... Show more

0 similar articles

3

2

Metro (British newspaper)

D+

Feb 15

'It is actions such as these that demonstrate the true heart and soul of the Met'trib.al/OO6WTTk

3

12

Neue Zürcher Zeitung

B

Jan 11

Popular weight loss injections: Eli Lilly and Novo Nordisk are chasing records: Investors expect record-high sales from new therapies to treat obesity. However ...

nzz.ch/wirtschaft/beliebte-abnehmspritzen-eli-lilly-und-novo-nordisk-jagen-rekorde-ld.1773336

0 similar articles

1

0 0

SeekingAlpha Apr 23

Novartis AG 2024 Q1 - Results - Earnings Call Presentation: The following slide deck was published by Novartis AG in conjunction with their 2024 Q1 earnings call ...

seekingalpha.com/article/4685255-novartis-ag-2024-q1-results-earnings-call-presentation

0

Mar 28

Harvard removes human skin binding from 19th century book: The Harvard Library announced Wednesday it removed a human skin binding from a 19th century book that ...

thehill.com/homenews/education/4561766-harvard-to-remove-human-skin-binding-book/

Quick Glance: Harvard University Removes Human Skin Binding from Infamous Library Book

Harvard University has removed the human skin binding from the infamous book 'Des Destinées de l’Ame,' housed in the Houghton Library of the university.

The 19th-century text by Arsène Houssaye was bound using stolen skin from a deceased female medical patient.

The university is working to research the patient's origins and collaborating with authorities to determine a respectful disposition of these human remains.

Harvard apologized for past failures and emphasized the removal of the skin binding as part of recommendations from the Report of the Harvard University Steering Committee on Human Remains in University Museum Collections.

0

Apr 08

Leader - For those in peril on the sea: None of us knows when we might be in need of the RNLI

scotsman.com/news/opinion/leader-for-those-in-peril-on-the-sea-4582321

0

17h

USFDA gives nod to Novartis’ therapy for rare cancer among children: The study reported a safety profile consistent with the adult population studied in NETTER-1 ...

financialexpress.com/healthcare/pharma-healthcare/usfda-gives-nod-to-novartis-therapy-for-rare-cancer-among-children/3468162/